Recursion

Recursion is a clinical-stage technology and biology company founded in 2013. It applies artificial intelligence to industrialize the process of drug discovery, aiming to decode biological systems to develop new therapies. The company operates at the intersection of the pharmaceutical, biotechnology, and technology sectors.

Central to its approach is the Recursion Operating System (Recursion OS), a platform built on one of the world's largest proprietary biological and chemical datasets, which exceeds 50 petabytes in size. This data is generated through an automated wet laboratory that uses robotics and computer vision to capture millions of cellular experiments each week, creating a continuous feedback loop for its AI models. To process this volume of information, Recursion developed BioHive-2, a supercomputer built in collaboration with NVIDIA, which is among the most powerful in the pharmaceutical industry.

The company's technical work spans artificial intelligence, computer vision, robotics, biology, and chemistry. By integrating these disciplines, Recursion seeks to systematically explore biological complexity and accelerate the identification of potential drug candidates.